link to article

New study could help decide whether chelation benefits the heart

Chelation therapy has long been scorned by many in the medical community. But after a major study suggested it was somewhat effective for heart disease, the alternative health treatment is once again going under the microscope. A second study called TACT 2 (Trial to Assess Chelation Therapy) will assess chelation’s heart-health benefits for patients with diabetes.

Watch the video and read the full story.

link to article

Free info session on diabetes, heart disease, and TACT2

TACT2 investigator Dr. Richard Nahas will present a free information session on diabetes, heart disease, and the TACT2 study on Tuesday, February 13, 7:00–8:30 p.m., at Ben Franklin Place in Ottawa, ON. RSVP required. Contact 613.727.7246 or for more information.

Listen to Dr. Nahas talk about the history, goals, and significance of TACT2 in the video below.